Has Christopher Jones, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,882 in general payments to Christopher Jones, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Jones, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Jones, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Jones, MD

Otolaryngology · Fort Mill, SCNPI 1346321650

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.

$3,882in general payments, 2019–2025

Across 76 payments — averaging $51.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$903
Sanofi$584
AstraZeneca$280
Optinose US, Inc.$267
Medtronic$266
Neurent Medical Limited$265
plus $1K from 15 others

What the payments were for

Food & beverage$3,882100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	16	$903
Sanofi	16	$584
AstraZeneca	4	$280
Optinose US, Inc.	5	$267
Medtronic(2 entities)	3	$266
Neurent Medical Limited	5	$265
Aerin Medical Inc.	2	$243
Regeneron Healthcare Solutions, Inc.	2	$233
Merz North America, Inc.	2	$191
GSK	4	$172
Acclarent, Inc	3	$103
AbbVie	1	$100
Tris Pharma Inc	4	$80
Peerless Surgical Inc.	1	$47
Intersect ENT, Inc.	2	$33
Collegium Pharmaceutical, Inc.	1	$23
Stryker	1	$23
Alcon	1	$23
Johnson & Johnson	1	$16
Cook Medical LLC	1	$16
Hikma Pharmaceuticals USA	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$639
DUPIXENT$574
VIVAER STYLUS$243
RHINAER STYLUS$243
NEUROMARK Device$140
NEUROMARK Radiofrequency Generator$140
PROPEL$137
NUCALA$124
TEZSPIRE$120
Xhance$120
Inspire Upper Airway Stimulation System$114
FUSION$110

How this compares

$3,882 in reported general payments places this provider in the 80th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$238,361

Medicare patients

638

Services billed

2,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	171	$4,860
Fluticasone Propionate	297	$4,348
Mometasone Furoate	23	$1,971
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	17	$1,908
Prednisolone Acetate	19	$1,265
Ofloxacin	45	$1,205
Cefdinir	42	$1,129
Fluocinolone Acetonide Oil	17	$858
Famotidine	127	$773
Azelastine Hcl	26	$767
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort	14	$756
Doxycycline Monohydrate	35	$689
Levothyroxine Sodium	36	$379
Omeprazole	49	$355
Prednisone	80	$241

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fort Mill

Jeffrey BrinkFort Mill$9K
Richard GillespieFort Mill$6K
Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Peter HorwichNorth Charleston$33K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →